W
UTMD icon

WealthCollab’s Utah Medical Products UTMD Stock Holding History

WealthCollab’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5K Hold
186
– – ﹤0.01% 508
2025
Q4 		$10.4K Hold
186
– – ﹤0.01% 554
2025
Q3 		$11.7K Hold
186
– – 0.01% 488
2025
Q2 		$10.6K Buy
+186
New +$10.1K 0.01% 479
2025
Q1 		– Sell
-71
Closed -$4.37K – 966
2024
Q4 		$4.37K Sell
71
-76
-52% -$4.91K ﹤0.01% 620
2024
Q3 		$9.84K Buy
147
+76
+107% +$5.16K 0.01% 459
2024
Q2 		$4.74K Buy
71
+55
+344% +$3.74K ﹤0.01% 603
2024
Q1 		$1.14K Buy
+16
New +$1.2K ﹤0.01% 814

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WealthCollab's UTMD Position: Q1 2026 in Review

WealthCollab held its Utah Medical Products (UTMD) position steady in Q1 2026 at 186 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

WealthCollab first reported a position in UTMD in Q1 2024 and has held it in 8 quarters since. The position peaked at $11.7K in Q3 2025. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • WealthCollab held 186 shares of Utah Medical Products worth $11.5K as of Q1 2026.
  • WealthCollab left its Utah Medical Products share count unchanged in Q1 2026.
  • Utah Medical Products made up ﹤0.01% of WealthCollab's portfolio in Q1 2026, its #508 holding.
  • WealthCollab first reported a position in Utah Medical Products in Q1 2024 and has held it in 8 quarters since.
  • WealthCollab's Utah Medical Products position peaked at $11.7K in Q3 2025.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.